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Enantioselective Formal Synthesis of (+)-Madangamine A 
Celeste Are, a Maria Pérez,b Joan Bosch,a and Mercedes Amat*a 
An enantioselective formal synthesis of the marine alkaloid 
madangamine A using phenylglycinol-derived lactam 1 as the 
starting enantiomeric scaffold is reported. The synthesis involves 
the construction of the C-9 substituted diazatricyclic ABC core and 
the final closure of D and E rings from the polyunsaturated skipped 
intermediate 19. 
Madangamine alkaloids1 are a small family (six members 
isolated so far) of complex marine natural products isolated 
from sponges of the order Haplosclerida.2 They are 
biogenetically derived from partially reduced bis-3-alkylpyridine 
macrocycles through a pathway that involves a skeletal 
rearrangement of ingenamine-type precursors.3 Structurally, 
madangamines are pentacyclic diamines embodying a 
diazatricyclic core (ABC rings) and two peripheral macrocyclic  
 
 
Fig. 1 Alkaloids of the madangamine group. 
rings. In madangamines AE, ring E is an 11-membered ring that 
incorporates a (Z,Z)-skipped diene with a trisubstituted double 
bond, whereas ring D differs in each one, both in size (13-, 14-, 
or 15-membered) and in the number and position of double 
bonds. Madangamine F features a tetraunsaturated 13-
membered E ring and an additional C-4 hydroxy substitutent 
(Figure 1). Madangamines A, D, and F have exhibited significant 
in vitro cytotoxicity against a variety of human cancer cell lines. 
The unique structure of madangamines has attracted 
considerable synthetic interest, resulting in a number of model 
studies for the construction of the diazatricyclic ABC core4 and 
for the assembly of the macrocyclic E5 and D rings.6 These 
studies have culminated in the first total enantioselective 
syntheses of madangamine D7 and madangamines A, C, and E.8 
Our synthesis of (+)-madangamine D allowed the absolute 
configuration of this alkaloid family to be confirmed.7 
We present herein an enantioselective formal synthesis of (+)-
madangamine A. Our general synthetic approach to 
mandangamines takes advantage of the versatility of 
phenylglycinol-derived lactams as enantiomeric scaffolds9 to 
build enantiopure complex polycyclic nitrogen-containing 
derivatives.10 The initial construction of an appropriately 
substituted and functionalized diazatricyclic platform 
embodying rings ABC of the alkaloids is followed by the 
assembly of the peripheral macrocyclic D and E rings.  
For the synthesis of the target madangamine A, starting from 
the same bicyclic lactam 1 as in our previous synthesis of 
madangamine D, we initially envisaged the generation of a C-911 
3-butynyl-substituted diazatricylic intermediate A, which would 
allow the incorporation of the unsaturated eight-carbon 
fragments, on C-29 and C-3, needed for the construction of the 
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Scheme 1 Synthetic strategy. 
 
Scheme 2 outlines the preparation of the key intermediate 8 
and our initial attempts to incorporate the skipped (Z,Z,Z)-
dodecatriene chain required for the closure of the D ring. 
Lactam 1 was stereoselectively converted to cis-
octahydroisoquinolone 2 in five steps and 62% overall yield, as 
previously reported.12 This multistep sequence involves the 
initial generation of an unsaturated lactam bearing an 
additional methoxycarbonyl activating substituent, a 
stereoselective conjugate addition of an allyl group to create 
the C-12 stereocenter, a ring-closing metathesis reaction to 
construct the carbocyclic C-ring, and a stereoselective alkylation 
of the -dicarbonyl moiety to generate the C-9 quaternary 
stereocenter. 
After reductive cleavage of the benzylic CN bond, 
simultaneous LiAlH4 reduction of the hemiaminal and carbonyl 
groups, and N-Boc protection, the closure of the piperidine A 
ring from cis-octahydroisoquinoline 3 was efficiently 
accomplished (54% overall yield) via an intermediate azido 
epoxide generated by a mesylation-azidation-epoxidation 
sequence. Reduction of the azido group under Staudinger 
reaction conditions provided a transient amino epoxide that 
underwent smooth in situ cyclization to give a tricyclic amino 
alcohol, which was protected as the N-tosyl derivative 5. 
The next step of the synthesis was the generation of the alkynyl 
moiety needed for the incorporation of the eight-carbon 
fragment en route to the closure of the D ring. After protection 
of the hydroxy function of 5 as a benzoate (6) and acid 
hydrolysis of the acetal group, homologation of the resulting 
crude aldehyde with the Ohira-Bestmann reagent (dimethyl 1-
diazo-2-oxopropylphosphonate) in the presence of potassium 
carbonate and methanol generated the required butynyl 
appendage.13 The basic reaction conditions of the 
homologation reaction also brought about deprotection of the 
hydroxy group, leading to alkynyl alcohol 7, which was then 
oxidized to tricyclic ketone 8. 
In the light of our model studies from a simple (3-
butynyl)piperidine,5b the construction of the skipped14 (Z,Z,Z)-
unsaturated 15-membered ring of madangamine A was 
attempted by cross-coupling of terminal alkyne 8 with 
octadiynyl bromide 12 and subsequent stereoselective 
reduction of the resulting triyne derivative 9. Unfortunately, 
although the coupling reaction satisfactorily afforded the 
skipped triyne 9, the hydroboration/protonolysis of 9 with 
dicyclohexylborane and AcOH resulted in the degradation of the 
starting material, in contrast with the results obtained in the 
model series. 
The required octadiyne 12 was prepared in excellent overall 
yield by cuprous iodide catalyzed coupling of propargyl alcohol 
with the orthogonally protected pentynediol 10, followed by 
functional group interconversions, as outlined in Scheme 3.15 
 
 




Scheme 2 First approach to (+)-madangamine A. 
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Scheme 4 Formal synthesis of (+)-madangamine A.
 
To avoid the manipulation of highly unstable polyacetylenic 
intermediates, we devised an alternative approach in which the 
eight-carbon fragment used in the cross-coupling reaction with 
the terminal alkyne would be a skipped octadiene. To also 
minimize the manipulation of sensitive skipped dienyne or 
triene intermediates, the coupling reaction was performed 
from a more advanced intermediate already incorporating the 
octadienoate chain required for the closure of the E ring. 
For this reason, tricyclic alcohol 5 was oxidized to ketone 14, 
which was treated under strictly anhydrous conditions with the 
nonstabilized ylide generated from the phosphonium salt 15,16 
previously used in our synthesis of madangamine D (Scheme 4). 
The resulting inseparable mixture (Z,Z/E,Z, 4:1 ratio) of dienes 
16 was then converted to C-9 butynyl derivative 17 following 
the previously used hydrolysis/OhiraBestmann homologation 
sequence.  
The skipped Z,Z-octadienyl bromide 13, required for the cross-
coupling reaction with 17, was stereoselectively prepared from 
diyne 11 as shown in Scheme 3. A partial cis-hydrogenation of 
11 with Brown’s P2-Ni catalyst (generated by in situ reduction 
of nickel acetate tetrahydrate with sodium borohydride in 
methanol in a hydrogen atmosphere),17 in the presence of 1,2-
diaminoethane as a catalyst modifier to increase the cis-
selectivity, afforded a Z,Z-dienyl alcohol intermediate, which 
was converted to bromide 13 via the corresponding mesylate.  
As expected, the cuprous iodide catalyzed coupling of terminal 
alkyne 17 with allyl bromide 13, followed by stereoselective 
reduction of the resulting dienyne 18 using the Brown P2-Ni 
catalyst system, generated the required skipped Z,Z,Z-triene 
moiety.18 A subsequent exchange of the TIPS protecting group 
for tosyl, able to act as a leaving group, provided the advanced 
intermediate 19, which incorporates all the skeletal atoms of 
the target madangamine A. 
At this point, only the closure of the macrocyclic D and E rings 
was required to complete the synthesis. This was accomplished 
without purification of the potentially sensitive 
polyunsaturated intermediates. Closure of the D ring was 
effected by intramolecular alkylation, after acid removal of N-
Boc protecting group. Finally, deprotection of the N-tosyl group, 
followed by alkaline hydrolysis and macrolactamization of the 
resulting crude amino acid, furnished the known pentacyclic 
lactam 21, which had previously been converted8 to (+)-
madangamine A. 
In conclusion, the above synthesis of (+)-madangamine A 
confirms the viability of the general strategy we are exploring 
to access the various members of this alkaloid family, using 
phenylglycinol-derived lactam 1 as the common starting 
enantiomeric scaffold. The tactically versatile functionality of 1 
enables the elaboration of the diazatricyclic core (rings ABC) of 
the target alkaloids, which serves as a platform to construct the 
macrocyclic D and E rings. Thus, the macrocyclic E ring common 
to madangamines A-E can be built taking advantage of the C-3 
carbonyl group using a straightforward Wittig/ 
macrolactamization sequence with an eight-carbon ylide, 
whereas the different D rings present in madangamines can be 
assembled by manipulating the length and adjusting the 
functionality of the chain at the quaternary C-9 stereocenter. In 
the synthesis of madangamine A, the assembly of the 
triunsaturated 15-membered D ring is accomplished by 
cyclization of a skipped (Z,Z,Z)-dodecatrienyl tosylate 19, 
generated from a diazatricyclic intermediate bearing a 3-
butynyl substituent at C-9. 
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